# Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes

> **NCT06245083** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Oklahoma**

## Conditions studied

- Maternal Obesity

## Interventions

- **DRUG:** Pyrroloquinoline quinone (PQQ)
- **DRUG:** Placebo with soybean oil

## Key facts

- **NCT ID:** NCT06245083
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator did not return submission for final IRB approval. Study was withdrawn by IRB.
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245083, "Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06245083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*